Public Company News

CNOOC Limited Announces Liza Phase II Commences Production

HONG KONG, Feb. 14, 2022 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883) announced today that Liza Phase II had commenced production safely and ahead of schedule. Liza Phase II locates in the Stabroek Block offshore Guyana and produces with 1 FPSO and 30 subsea wellheads. The FPSO is ...

2022-02-14 08:27 6127

U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio

SAN FRANCISCO and SUZHOU, China, Feb. 14, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2022-02-14 08:00 4995

Visionflex Chooses Vonage to Power its Next-Generation Remote Healthcare and Diagnostic Services

HOLMDEL, N.J., Feb. 14, 2022 /PRNewswire/ -- Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen byVisionflex to power the future of telehealth and remote diagnostic equipment for medical professionals through th...

2022-02-14 06:32 3392

Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries

HANGZHOU, China and SHAOXING, China, Feb. 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) inGermany, France, Ireland and United Kingdom through its agent in Europe. It i...

2022-02-13 18:30 5216

China Literature and Singapore's Top Two Universities Launch Platform to Nurture Passionate Young Authors

SINGAPORE, Feb. 12, 2022 /PRNewswire/ -- China Literature (0772.HK), a leading online literature and intellectual property (IP) incubation platform inChina, established the Global Author Incubation Project 2022 onFebruary 11, 2022, as part of its ongoing commitment to providing creative guidance ...

2022-02-12 15:00 6932

Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results

JIUQUAN, China, Feb. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), aChina-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the fiscal year ...

2022-02-12 06:05 6949

SHELL MIDSTREAM PARTNERS, L.P. RECEIVES OFFER FOR REMAINING UNITS FROM SHELL PIPELINE COMPANY L.P.

HOUSTON, Feb. 11, 2022 /PRNewswire/ -- Shell Midstream Partners, L.P. (NYSE: SHLX) ("SHLX" or the "Partnership") announces that it has received a non-binding, preliminary proposal letter from Shell Pipeline Company LP ("SPLC") to acquire all of the Partnership's issued and outstanding common uni...

2022-02-11 22:20 7557

SHELL PIPELINE COMPANY LP ANNOUNCES OFFER FOR REMAINING UNITS OF SHELL MIDSTREAM PARTNERS, L.P.

HOUSTON, Feb. 11, 2022 /PRNewswire/ -- Shell Pipeline Company LP ("Shell") today announces it has made a non-binding offer to purchase all remaining common units held by the public representing limited partner interests in Shell Midstream Partners, L.P. (NYSE: SHLX) ("SHLX") for$12.89 per common ...

2022-02-11 22:15 7680

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for January 2022

CHENGDU, China, Feb. 11, 2022 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina, as well as an operator of its own online ride-hailing platform, today announced the operatin...

2022-02-11 22:00 4006

Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients

SUZHOU, China, Feb. 11, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the enrollment and dosing of first patient inChina in its multi-regi...

2022-02-11 20:40 4894

Ucommune Announces Development of an Asset-light Digital Park Project in Shenfu, Liaoning

BEIJING, Feb. 11, 2022 /PRNewswire/ -- Ucommune International Ltd. (NASDAQ: UK) ("Ucommune" or the "Company"), a leading agile office space manager and provider inChina, today announced that the Company has entered into an agreement (the "Agreement") with Xincheng Enterprise Management Co., Ltd. ...

2022-02-11 19:30 4689

Crunchfish Gesture Interaction - the versatile Skeleton platform

STOCKHOLM, Sweden, Feb. 11, 2022 /PRNewswire/ -- Crunchfish's Gesture Interaction technology has evolved to a versatile Skeleton platform that addresses many gesture interaction scenarios in AR/VR, public screens as well as automotive applications. Crunchfish's Skeleton platform was the topic of ...

2022-02-11 19:29 4699

Snow Much Adventure: Yadea Powers Boundless Outdoor Sports and Activities this Winter

MUNICH, Feb. 11, 2022 /PRNewswire/ -- With the winter sports season in full swing, Yadea (01585:HK), the world's leading electric two-wheeler brand, is empowering people around the world to participate in outdoor sports and activities with its rich product portfolio. With cold-resistant battery ...

2022-02-11 19:07 5222

Marriott Bonvoy Portfolio of Resorts in Bali Teams Up with Bali.com to Provide Guests with a Seamless Travel Experience for the Re-Opening of Bali

BALI, Indonesia, Feb. 11, 2022 /PRNewswire/ -- With the recent announcement of the re-opening ofBali's borders to international travelers, Marriott Bonvoy resorts inBali, announces a strategic collaboration with Bali.com to elevate travel and quarantine experience for holidaym...

2022-02-11 17:02 6533

Lifestyle retailer MINISO donates $153,300 USD to plant 115,000 trees in the Andes

GUANGZHOU, China, Feb. 11, 2022 /PRNewswire/ -- Lifestyle retailer MINISO is proud to announce its global fundraising effort with Peruvian NGO ECOAN (Asociación Ecosistemas Andinos), has succeeded in donating$153,300 US dollars for a reforestation program in the Andes mountains. The success of th...

2022-02-11 15:53 5712

Information from Mycronic's Nomination Committee

STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- The Nomination Committee of Mycronic AB (publ) proposes ahead of the Annual General Meeting onMay 5, 2022, the re-election of Patrik Tigerschiöld,Arun Bansal, Anna Belfrage, Katarina Bonde, Staffan Dahlström andRobert Larsson and the election of Bo Risberg...

2022-02-11 15:18 3340

Hyundai Motor Group Takes Top Honors in 2022 J.D. Power U.S. Vehicle Dependability Study

* Owners of vehicles from Hyundai Motor Group nameplates report the fewest problems and frustrations compared to owners of other automotive brands in the U.S. * Kia ranks top brand overall and Genesis ranks top premium brand * Hyundai Motor ranks third overall, improving by four positions SE...

2022-02-11 15:00 3321

BRI Microfinance Outlook 2022: BRI Continues Supporting Ultra-Micro Sector for Economic Recovery

JAKARTA, Indonesia, Feb. 11, 2022 /PRNewswire/ -- Bank BRI (IDX: BBRI), has announced its commitment to support the MSME sector inIndonesia to empower the ultra-micro sector at the BRI Microfinance Outlook 2022 onFebruary 10, 2022. The event was attended by Sri Mulyani, Minister of Finance; Air...

2022-02-11 12:20 7431

Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial

- PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population - Trial demonstrated 82% clinical efficacy against Delta variant - Immune responses were about two-to-three-fold higher in adolescents than in...

2022-02-11 10:45 4919

FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission

SAN FRANCISCO, and SUZHOU, China, Feb. 11, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) held a public Oncology Drug Advisory Committee (ODAC) for sintilimab, which is under review for the first-line treatment of people with non-squamous non-small cell lung cancer (nsqNSCLC) ba...

2022-02-11 10:44 4824

Week's Top Stories